AAAAAA

   
Results: 1-12 |
Results: 12
PRIMARY CONJUNCTIVAL RHABDOMYOSARCOMA - 2.5 YEARS FOLLOW-UP AFTER COMBINED CHEMOTHERAPY AND BRACHYTHERAPY
Authors: SEKUNDO W ROGGENKAMPER P FISCHER HP FLEISCHHACK G FLUHS D SAUERWEIN W
Citation: W. Sekundo et al., PRIMARY CONJUNCTIVAL RHABDOMYOSARCOMA - 2.5 YEARS FOLLOW-UP AFTER COMBINED CHEMOTHERAPY AND BRACHYTHERAPY, Graefe's archive for clinical and experimental ophthalmology, 236(11), 1998, pp. 873-875
HIGH-DOSE CHEMOTHERAPY WITH THIOTEPA, CARBOPLATIN, ETOPOSIDE AND AUTOLOGOUS STEM-CELL TRANSPLANTATION IN THE TREATMENT OF POOR-PROGNOSIS MALIGNANT BRAIN-TUMORS - RESULTS OF A MONOCENTER PILOT-STUDY
Authors: FLEISCHHACK G POPPING K HASAN C UTSCH B JUTTNER J BODE U
Citation: G. Fleischhack et al., HIGH-DOSE CHEMOTHERAPY WITH THIOTEPA, CARBOPLATIN, ETOPOSIDE AND AUTOLOGOUS STEM-CELL TRANSPLANTATION IN THE TREATMENT OF POOR-PROGNOSIS MALIGNANT BRAIN-TUMORS - RESULTS OF A MONOCENTER PILOT-STUDY, Klinische Padiatrie, 210(4), 1998, pp. 248-255
IDA-FLAG (IDARUBICIN, FLUDARABINE, CYTARABINE, G-CSF), AN EFFECTIVE REMISSION-INDUCTION THERAPY FOR POOR-PROGNOSIS AML OF CHILDHOOD PRIOR TO ALLOGENEIC OR AUTOLOGOUS BONE-MARROW TRANSPLANTATION - EXPERIENCES OF A PHASE-II TRIAL
Authors: FLEISCHHACK G HASAN C GRAF N MANN G BODE U
Citation: G. Fleischhack et al., IDA-FLAG (IDARUBICIN, FLUDARABINE, CYTARABINE, G-CSF), AN EFFECTIVE REMISSION-INDUCTION THERAPY FOR POOR-PROGNOSIS AML OF CHILDHOOD PRIOR TO ALLOGENEIC OR AUTOLOGOUS BONE-MARROW TRANSPLANTATION - EXPERIENCES OF A PHASE-II TRIAL, British Journal of Haematology, 102(3), 1998, pp. 647-655
CYANOTIC RAYNAUDS-PHENOMENON WITH CONVENTIONAL BUT NOT WITH LIPOSOMALAMPHOTERICIN-B - 3 CASE-REPORTS
Authors: ZERNIKOW B FLEISCHHACK G HASAN C BODE U
Citation: B. Zernikow et al., CYANOTIC RAYNAUDS-PHENOMENON WITH CONVENTIONAL BUT NOT WITH LIPOSOMALAMPHOTERICIN-B - 3 CASE-REPORTS, Mycoses, 40(9-10), 1997, pp. 359-361
IDA-FLAG (IDARUBICIN, FLUDARABINE, HIGH-D OSE CYTARABINE, GRANULOCYTE-COLONY-STIMULATING FACTOR) - AN EFFECTIVE REGIMEN IN RELAPSED ACUTE MYELOGENOUS LEUKEMIA IN CHILDHOOD
Authors: FLEISCHHACK G GRAF N HASAN C ACKERMANN M BREU H ZERNIKOW B BODE U
Citation: G. Fleischhack et al., IDA-FLAG (IDARUBICIN, FLUDARABINE, HIGH-D OSE CYTARABINE, GRANULOCYTE-COLONY-STIMULATING FACTOR) - AN EFFECTIVE REGIMEN IN RELAPSED ACUTE MYELOGENOUS LEUKEMIA IN CHILDHOOD, Klinische Padiatrie, 208(4), 1996, pp. 229-235
RAYNAUDS-PHENOMENON AS ADVERSE EFFECT OF AMPHOTERICIN-B
Authors: ZERNIKOW B FLEISCHHACK G HASAN C BODE U
Citation: B. Zernikow et al., RAYNAUDS-PHENOMENON AS ADVERSE EFFECT OF AMPHOTERICIN-B, Klinische Padiatrie, 208(2), 1996, pp. 53-55
PERSONAL TIME MANAGEMENT IN-HOSPITAL
Authors: ZERNIKOW B MICHEL E JACOBS C FLEISCHHACK G HASAN C BODE U
Citation: B. Zernikow et al., PERSONAL TIME MANAGEMENT IN-HOSPITAL, Monatsschrift fur Kinderheilkunde, 144(6), 1996, pp. 627-635
LOSS OF ACTIVITY OF ERWINIA ASPARAGINASE ON REPEAT APPLICATIONS
Authors: BOOS J NOWAKGOTTL U JURGENS H FLEISCHHACK G BODE U
Citation: J. Boos et al., LOSS OF ACTIVITY OF ERWINIA ASPARAGINASE ON REPEAT APPLICATIONS, Journal of clinical oncology, 13(9), 1995, pp. 2474-2475
VENOOCCLUSIVE DISEASE AND CAPILLARY LEAK SYNDROME AS COMPLICATIONS INTHE TREATMENT OF WILMS-TUMOR
Authors: FLEISCHHACK G BODE U
Citation: G. Fleischhack et U. Bode, VENOOCCLUSIVE DISEASE AND CAPILLARY LEAK SYNDROME AS COMPLICATIONS INTHE TREATMENT OF WILMS-TUMOR, Monatsschrift fur Kinderheilkunde, 143(8), 1995, pp. 792-793
THERAPY OF NON-B-CELL MALIGNANT NON-HODGK INS-LYMPHOMA OF CHILDHOOD AND ADOLESCENCE - AN INTERIM ANALYSIS OF STUDY NHL-BFM-90 .2.
Authors: REITER A SCHRAPPE M YAKISAN E SAUTER S HENZLER D ZIMMERMANN M GRAF N FENGLER R KUHL J FLEISCHHACK G DORFFEL W KLUBA U RIEHM H
Citation: A. Reiter et al., THERAPY OF NON-B-CELL MALIGNANT NON-HODGK INS-LYMPHOMA OF CHILDHOOD AND ADOLESCENCE - AN INTERIM ANALYSIS OF STUDY NHL-BFM-90 .2., Klinische Padiatrie, 206(4), 1994, pp. 234-241
CT AND MRI FINDINGS OF CEREBROVASCULAR CO MPLICATIONS OF L-ASPARAGINASE THERAPY
Authors: FLEISCHHACK G SOLYMOSI L REITER A BENDERGOTZE C EBERL W BODE U
Citation: G. Fleischhack et al., CT AND MRI FINDINGS OF CEREBROVASCULAR CO MPLICATIONS OF L-ASPARAGINASE THERAPY, Klinische Padiatrie, 206(4), 1994, pp. 334-341
VENOOCCLUSIVE DISEASE (VOD) OF THE LIVER AS A COMPLICATION OF CHEMOTHERAPY OF WILMS-TUMOR
Authors: FLEISCHHACK G FUNCKE A BODE U
Citation: G. Fleischhack et al., VENOOCCLUSIVE DISEASE (VOD) OF THE LIVER AS A COMPLICATION OF CHEMOTHERAPY OF WILMS-TUMOR, Monatsschrift fur Kinderheilkunde, 142(10), 1994, pp. 781-783
Risultati: 1-12 |